[144] Mueller Industries, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) – Form 4 insider transaction

Chief Legal Officer Soleil Boughton filed a Form 4 reporting the sale of 2,572 Class A common shares on 30 Jun 2025 under a previously established Rule 10b5-1 trading plan adopted 28 Aug 2024. The shares were sold at a stated price of $50.50 each (transaction code “S”), reducing Boughton’s directly held position to 160,737 shares. No derivative securities were involved and no additional acquisitions were reported.

The transaction represents roughly 1.6 % of the officer’s post-transaction holdings and generated proceeds of approximately $129 k. Because the sale was executed pursuant to a 10b5-1 plan, it is generally viewed as pre-scheduled rather than opportunistic. No other executives or directors were listed on this filing.

From a governance perspective, the filing signals routine portfolio diversification rather than a material change in insider sentiment. Investors may monitor future filings for patterns or larger-scale disposals, but this single, modest sale is unlikely to alter the fundamental investment thesis for HIMS.

Insights

Securities Analyst

TL;DR: Small 10b5-1 sale; neutral impact.

The Chief Legal Officer’s disposition of 2,572 shares (≈ $129 k) represents a minor portion of her stake and was executed under a pre-arranged 10b5-1 plan, limiting the informational value of the sale. Remaining ownership of 160,737 shares maintains significant alignment with shareholders. Given the modest size and pre-scheduled nature, I view the transaction as neutral for valuation and sentiment. Continued monitoring of insider activity is prudent, but this filing alone does not suggest a shift in corporate outlook.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	JP Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	19585	1556420	110649746	07/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/02/2024	Vested restricted shares	Issuer			19585	08/02/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steffen Sigloch C/o Mueller Industries, Inc. 150 Schilling Boulevard, Suite 100 Collierville TN 38017	Common Stock	04/03/2025	19584	1466103
Steffen Sigloch C/o Mueller Industries, Inc. 150 Schilling Boulevard, Suite 100 Collierville TN 38017	Common Stock	05/12/2025	19584	1521133

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares did the insider sell?

The Form 4 reports a sale of 2,572 Class A common shares.

At what price were the HIMS shares sold?

The stated sale price was $50.50 per share.

What is the insider's remaining HIMS shareholding?

After the sale, the officer directly owns 160,737 shares.

Was the transaction part of a Rule 10b5-1 plan?

Yes. The sale was executed under a 10b5-1 trading plan adopted on 28 Aug 2024.

Does this filing signal a major change in insider sentiment at HIMS?

Given the modest size (≈ 1.6 % of holdings) and pre-scheduled nature, the filing is generally viewed as neutral.